MedPath

Prenatel surgery of the fetal spina bifida in hybrid method within the fetoscopic Myelomeningocele Repair Consortium

Not Applicable
Recruiting
Conditions
Q05.9
Spina bifida, unspecified
Registration Number
DRKS00026102
Lead Sponsor
niversitätsklinikum Giessen und Marburg, Standort Giessen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

age >/= 18 years
-Informed Consent
-Localisation of defect between Th1 and S1 and -Arnorld Chiari II malformation (confirmation by MRI)
-Gestational age between 19+0 – 28+0 weeks when operation
-normal karyotype

Exclusion Criteria

- A multiple pregnancy (twins)
- A cervix length of < 25 mm (established through transvaginal sonography)
sonography)
- A cerclage (planned or in place) or a cervix closure
- A anamnestic risk of premature birth (condition resulting from cervical insufficiency) or spontaneous partum <37+ week by a single pregnancy
- Placenta praevia, placental abruption

- Fetal abnormalities not associated with the malformation of the central nervous system, (fetal-echography before obligatory randomization);
- Obesity (BMI * 35 kg/m2);
- A prior, insulin dependent diabetes mellitus (type I or II)
- An arterial, maternal hypertension (not arterial or chronic with end organ damage, newly developed hypertension during the current pregnancy)
- A kyphosis of 30°
- A Rh or Kell sensitivity, condition following neonatal alloimmune-thrombocytopenia (NAIT)
- A maternal infection with HIV, hepatitis B or C, uterine abnormalities or large/multiple myomas
- Maternal contraindications, for example hysterectomy in the active uterine segment, extended myoma enucleation, previous fetal surgery; insufficiently supportive social environment; difficulty in committing to post-treatment observation appointments at the Center; participation in another intervention study through which the maternal or fetal morbidity or mortality would be influenced, or, pre-pregnancy participation in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intrauterine death of fetus (IUFD); <br>Birthweight<br>Artificial respiration <br>Brain hemorrhage<br>Fetal retinopathy<br><br>Necessity of shunt after 12, 24 und 30 months functional level of free (unassisted) walking Continence<br>Necessity of catheterization<br>Necessity of post-partum revision<br>Neurological development up to 30 months post-partum<br><br><br>Maternal primary outcome parameter: <br>Gestational age<br>Premature rupture of the amnionic sack (PPROM)<br>Amnion separation<br>Detachment of the placenta<br>Amnio infection syndrome <br>Sectio rate <br>Wound dehiscence<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath